Glenmark gets USFDA approval for Clindamycin Phosphate Gel

It is an antibiotic indicated for the treatment of acne

Glenmark Pharmaceuticals has received final approval by the United States Food & Drug Administration (US FDA) for Clindamycin Phosphate Gel USP, 1%, the generic version of Cleocin T Gel, 1%, of Pharmacia & Upjohn.

It is an antibiotic indicated for the treatment of acne

According to IQVIA sales data for the 12 month period ending December 2020, the Cleocin T Gel, 1% market achieved annual sales of approximately $73.8 million*.

Glenmark’s current portfolio consists of 169 products authorised for distribution in the US marketplace and 42 ANDAs pending approval with the US FDA.

acneantibioticClindamycin Phosphate GelGlenmark PharmaUS FDA
Comments (0)
Add Comment